CCL2 and kidney disorder: In addition to increasing antioxidant enzymes, empagliflozin down-regulated gene expression of nephropathy markers (Hmox1, Ngal, Tgfβ1, Mcp-1), which are also involved in inflammatory and injury processes in the kidney cortex.